Status:
COMPLETED
Vascular Thrombus Involvement in Nephroblastoma
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Nephroblastoma With Vena Cava Thrombosis
Eligibility:
All Genders
Up to 17 years
Brief Summary
Nephroblastoma (Wilms tumor) is the most common kidney tumor in children. It is a malignant embryonic tumor with a good prognosis with more than 85% long-term survival with appropriate chemotherapy, s...
Detailed Description
Nephroblastoma (Wilms tumor) is the most common kidney tumor in children. It is a malignant embryonic tumor with a good prognosis with more than 85% long-term survival with appropriate chemotherapy, s...
Eligibility Criteria
Inclusion
- Minors with nephroblastoma with vena cava thrombosis +/- atrial extension.
- Cared between 1999 and 2019 in the centers of the study.
Exclusion
- \- Other renal and non-renal tumors with vena cava thrombosis.
Key Trial Info
Start Date :
December 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2023
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05195411
Start Date
December 12 2022
End Date
March 15 2023
Last Update
September 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Kremlin Bicêtre
Le Kremlin-Bicêtre, France, 94270
2
Hôpital Necker-Enfants Malades
Paris, France, 75015